|Bid||56.0000 x 600|
|Ask||56.0100 x 900|
|Day's Range||55.7700 - 56.1800|
|52 Week Range||46.0100 - 76.8000|
|PE Ratio (TTM)||19.45|
|Dividend & Yield||1.56 (2.80%)|
|1y Target Est||N/A|
Pharmaceutical giants Bristol-Myers Squibb Co (NYSE: BMY ) and Merck & Co., Inc. (NYSE: MRK ) both release their second quarter earnings reports this week. According to BMO Capital, investors should be ...
The overall contribution of the Innovative Medicines segment was ~67.6% at $8.28 billion for 2Q17.
Though the healthcare sector is expected to post an earnings decline and has a dismal Rank, some surprises may well be in the cards, suggesting upside for healthcare ETFs.